Asphyxia Clinical Trial
Official title:
Brain Research to Ameliorate Impaired Neurodevelopment (BRAIN): Home-based Intervention A Multicenter Trial of the Global Network for Women's and Children's Health Research
We plan to test a home-based parent-provided early developmental intervention (EI) both in
infants with mild to moderate birth asphyxia and in infants without perinatal complications
who will constitute a healthy comparison group in a randomized controlled trial. The trial
will evaluate the effect of a resource-intensive early intervention (EI) program on the
outcomes in infants born in rural communities in Zambia, India, and Pakistan. It will
consist of frequent interaction (every 2 weeks the first year and every 4 weeks the second
and third years) between parents and the parent trainer. The control group will receive
enhanced health counseling (HC).
The overall goal will be to implement and evaluate an EI program for infants following birth
asphyxia, which is sustainable in developing countries. The challenge will be to adapt
programs demonstrated to be effective in developed countries to the circumstances of the
developing world, while reducing the demands on resources. Because there are limited data on
normative development and EI programs in developing countries, a group of infants without
perinatal complications will also be randomized to the same conditions in order to provide a
comparison of what may be achieved from the intervention in healthy infants in developing
countries. A final aim will be to address individual variation in EI effects that could be
due to child and/or family characteristics.
A randomized controlled experimental design will be used, in which infants who survive
following birth asphyxia are randomly assigned to either EI or enhanced health education
counseling (HC). The trial will randomize infants to a home-based parent-provided early
developmental intervention (EI) with frequent home interaction between parents and parent
trainers vs. HC. A group of infants without birth asphyxia or other major perinatal
complications also will be randomized. Children will be examined by masked examiners at
three time points (12, 24, and 36 month's assessments).
n/a
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05836610 -
Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates
|
Phase 4 | |
Completed |
NCT03751774 -
The MAMAACT Intervention
|
N/A | |
Completed |
NCT02019147 -
BiHiVE2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy.
|
||
Active, not recruiting |
NCT05308303 -
AI to Improve Data From Danish Cardiac Arrest Registry
|
||
Completed |
NCT02700828 -
Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns
|
Phase 2/Phase 3 | |
Completed |
NCT01305031 -
Resuscitation of Late-preterm Infants by Using Room Air or 100% Oxygen
|
N/A | |
Completed |
NCT06254651 -
Resuscitation Table Height for Face-mask Ventilation in Infants
|
N/A | |
Completed |
NCT02379936 -
Evaluation of Lactate Dehydrogenase as Decision Support for Admissions to Neonatal Ward
|
N/A | |
Completed |
NCT02468310 -
Evaluating the Effects of SMS Text Messaging Support System Among Frontline Health Workers in Ghana
|
N/A | |
Not yet recruiting |
NCT00491413 -
Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth
|
Phase 1 |